Clinical application of pet

Brazilian Archives of Biology and Technology

Francisco Lomeña²  Marina Soler¹ 

[1] ,Nuclear Medicine Hospital Clínic VillarroelBarcelona,Spain

关键词: PET;    fluordeoxyglucose-F18 (FDG);    cancer;    PET/CT;   

DOI  :  10.1590/S1516-89132005000700027

来源: SciELO

【 摘 要 】

Positron emission tomography (PET) is an imaging modality that gives information on tissue metabolism and functionalism, different from other imaging techniques like computed tomography (CT) and magnetic resonance imaging (MRI), which provide anatomical or structural information. PET has reached its development in biomedical research because of its capacity to use analogous compounds of many endogenous substance as tracers, and to measure, in vivo and in a non-invasive way, their consumption by the different organs and tissues of the mammalian body. Fluordeoxyglucose-F18 (FDG) PET has been proven to be a tracer adequate for clinical use in oncology and in many neurological diseases, with an excellent cost-efficiency ratio. The current PET-CT scanners can come to be the best tools for exploring patients who suffer from cancer.

【 授权许可】

CC BY-NC   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License